PEGylation does not significantly change the initial intravenous or subcutaneous pharmacokinetics or lymphatic exposure of trastuzumab in rats but increases plasma clearance after subcutaneous administration.
Mol Pharm
; 12(3): 794-809, 2015 Mar 02.
Article
em En
| MEDLINE
| ID: mdl-25644368
Palavras-chave
Texto completo:
1
Base de dados:
MEDLINE
Assunto principal:
Trastuzumab
/
Antineoplásicos
Limite:
Animals
/
Humans
/
Male
Idioma:
En
Ano de publicação:
2015
Tipo de documento:
Article